Why Women Over 40 Feel So Tired: The NAD+ Connection Science Is Finally Explaining

Fatigue, brain fog, and sleep disruption in perimenopause may partly trace back to declining NAD+ levels. Here is what the science says and what you can do about it.

You eat well. You sleep, or try to. You exercise. And yet somewhere in your early-to-mid forties, an inexplicable tiredness settles in. Not the kind you can shake with coffee. A bone-deep depletion that sits underneath everything: your focus, your patience, your motivation, and your body's ability to bounce back.

You've probably been told it's stress. Or hormones. Or "just aging."

But emerging science is pointing to something more precise and more actionable. A molecule called NAD+ may sit at the center of why so many women in midlife feel energetically depleted, and why restoring it is becoming one of the more discussed strategies in longevity medicine.

What Is NAD+, and Why Should You Care?

NAD+ stands for nicotinamide adenine dinucleotide. It does not exactly roll off the tongue, but its job description is remarkable: this coenzyme is involved in over 500 enzymatic reactions in the body. It powers the mitochondria, your cells' energy generators. It activates sirtuins, the proteins linked to DNA repair and cellular longevity. It regulates your circadian rhythm, inflammation response, and metabolic efficiency.

In short, NAD+ is the molecular infrastructure of how you feel every day.

And here is the uncomfortable truth: you are making less of it with every passing year.

The Decline Is Real, and Often Steep

NAD+ concentrations in human tissues may be 10-80% lower in midlife and older adults compared with young adults, depending on the tissue measured [1]. In human skin samples, average NAD+ concentration appears to decline at least 50% over the course of adult aging, and can be several-fold lower in adults than in newborns [2].

That is not a minor fluctuation. It suggests your cellular energy machinery may be running with less reserve.

This decline accelerates for a specific reason: as we age, more enzymes that consume NAD+, like CD38, become more active, while the enzymes that synthesize NAD+ slow down [1]. The result is a compound deficit that affects almost every tissue in the body.

For women navigating perimenopause, there is an additional layer. Declining estrogen, the hormonal hallmark of this transition, directly affects mitochondrial function [3]. Research published in npj Metabolic Health and Disease in 2025 confirms that declining NAD+ levels are associated with aging and chronic disorders, including cognitive decline, sarcopenia, and metabolic diseases, with mitochondrial dysfunction as a central mechanism [3].

Brain Fog Is Not Just in Your Head, It Is in Your Cells

The mental fog that descends in midlife is one of the most commonly reported (and least clinically addressed) symptoms women experience. You lose words mid-sentence. You walk into a room and forget why. You reread the same paragraph four times.

This is not imagined, and it is not just hormonal.

Research published in Biomolecules (2024) found that reduced NAD+ levels are associated with alterations in mitochondrial function and an increase in reactive oxygen species, accompanied by a decline in oxidative metabolism, changes that can impair neuronal energy production and cognitive performance [4].

"NAD+ depletion, a hallmark of brain aging, further contributes to energetic failure; restoring NAD+ ameliorates pathology and improves cognition in several preclinical models."

npj Aging, 2025 [5]

A 2024 randomized, placebo-controlled pilot trial published in PMC studied nicotinamide riboside (NR), an NAD+ precursor, in older adults with mild cognitive impairment. The trial confirmed that NR supplementation produced a 2.6-fold increase in blood NAD+ levels (p < 0.001) and was well tolerated. The study also observed a NR-associated reduction in epigenetic age as measured by PhenoAge and GrimAge clock analyses, suggesting that restoring NAD+ may measurably slow aspects of the biological aging process [6].

The Fatigue-NAD+ Loop: Why Rest Is Not Always Enough

Here is something that surprises many people: sleep does not automatically fix NAD+ depletion. In fact, disrupted sleep, a near-universal complaint during perimenopause, can worsen NAD+ metabolism.

NAD+ is intimately linked to the circadian clock through a feedback loop involving the enzyme NAMPT (nicotinamide phosphoribosyltransferase), a key enzyme in NAD+ biosynthesis [2]. When your circadian rhythm is disrupted, NAD+ production drops. When NAD+ drops, the mitochondria produce less ATP, your cellular fuel. When ATP dips, every cell in your body, including muscle, brain, and immune cells, gets less energy to work with.

This is why fatigue in midlife often feels categorically different from simple tiredness. It is a systemic energy deficit operating at the cellular level.

A comprehensive systematic review in the American Journal of Physiology – Endocrinology and Metabolism (2024) evaluated clinical evidence across 10 randomized trials including 489 participants. The review found that NAD+ supplementation was well tolerated across multiple conditions and produced measurable clinical outcomes, including decreased anxiety, increased muscle insulin sensitivity, and improved quality of life and fatigue intensity scores in patients with chronic fatigue syndrome [7].

What the Research Says About Delivery Method

This is where injections become particularly relevant.

Oral NAD+ precursors (NMN, NR) have to survive digestion, cross the gut wall, and be converted by your cells before they reach the bloodstream as usable NAD+. Bioavailability can vary significantly by individual metabolism, gut health, and age-related changes in absorption.

Injectable NAD+ bypasses this entire process and enters the bloodstream directly. In practice, that may allow for a more direct rise in circulating NAD+ support than oral supplements. Clinicians using IV and subcutaneous NAD+ often report faster subjective responses, though individual results vary.

The 2024 review by de Mello Gindri et al. concluded that NAD-related supplementation across multiple delivery methods was generally safe in the studied clinical populations, with reported improvements in energy, metabolic markers, and cognitive wellbeing [7].

Who Is This Actually For?

If you are a woman in your late 30s to mid-50s, the question is not whether your NAD+ is declining, but how much, and whether it has crossed the threshold that is affecting your daily experience.

Signs that NAD+ depletion may be contributing to how you feel:

Persistent fatigue that sleep doesn't resolve
Mental fog: slower processing, word retrieval issues, difficulty concentrating
Workout recovery taking longer than it used to
Skin changes: dullness, reduced elasticity
Mood fluctuations that feel metabolic rather than situational
Low resilience to stress: the tanks feel emptier

This is not an exhaustive list. But these are the signals your cells are sending when mitochondrial efficiency drops.

The Longevity Angle: More Than Just Energy

The conversation around NAD+ is rapidly evolving beyond "energy boost" into genuine longevity science.

The sirtuins activated by NAD+, particularly SIRT1 and SIRT3, regulate DNA repair, reduce inflammation, and may influence the pace of cellular aging itself [3]. Declining NAD+ means declining sirtuin activity, which can accelerate the accumulation of cellular damage over time.

Research published in Nature in 2025 specifically identified NAD+ depletion as a key bridge between cellular senescence and neurodegenerative disease progression, with restoration of NAD+ showing therapeutic potential across multiple aging models [5].

For health-conscious women in midlife who are thinking not just about today's energy but about how they will feel at 60 and 70, this is the kind of upstream intervention worth paying attention to.

Pairing NAD+ With Other Strategies: A Systems Approach

One of the things that makes NAD+ therapy compelling is how it stacks with other wellness interventions. Because NAD+ is upstream of so many cellular processes, restoring it may amplify the benefits of other habits you are already practicing.

Exercise triggers NAMPT, the rate-limiting enzyme in NAD+ synthesis, which is part of why regular movement is so protective against aging. But as NAD+ declines, your cells become less responsive to exercise-induced repair, and recovery takes longer. Restoring NAD+ may help your body re-engage with more of the regenerative benefits of physical activity.

Sleep is when your body performs much of its cellular repair, including NAD+-dependent DNA maintenance. Supporting your NAD+ levels may improve sleep quality through circadian rhythm regulation, which then feeds back positively into energy production during the day.

Stress management matters because chronic psychological stress increases inflammation, which activates CD38, an NAD+-consuming enzyme. Lower your inflammatory burden, and you preserve more NAD+ for the processes that matter.

Think of NAD+ therapy not as a standalone fix, but as a cellular infrastructure upgrade that may help everything else you are doing work better.

A Physician-Guided Approach

NAD+ therapy isn't a supplement you add to your morning routine. It's a clinical intervention best administered under medical supervision, where dosing, timing, and protocol are tailored to your specific health picture.

At RenuviaRX, physician-supervised NAD+ injection therapy starts at $179/month and is designed around your individual wellness goals, whether that is sharper cognition, sustained energy, faster recovery, or supporting your long-term longevity strategy. The program is HIPAA-compliant, overseen by board-certified physicians, and compounded by Strive Pharmacy.

The Bottom Line

The fatigue, the fog, and the feeling that your body is not operating at the level it used to are rooted in biology, not weakness. NAD+ decline is a measurable, documented process that begins in your thirties and accelerates through midlife. The good news is that it is also potentially addressable.

Science is still deepening its understanding of NAD+ therapy, and larger long-term trials are ongoing. But the existing body of evidence, across human clinical trials, epigenetic analyses, and mechanistic research in leading journals, suggests that restoring NAD+ may be one of the more promising tools for reclaiming energy, mental clarity, and cellular vitality in midlife.

Ready to explore how NAD+ therapy might support your wellness goals? Start with a free physician assessment at RenuviaRX.

References

Covarrubias AJ et al. "NAD+ metabolism and its roles in cellular processes during ageing." Nature Reviews Molecular Cell Biology, vol. 22, no. 2, 2021, pp. 119–141. DOI: 10.1038/s41580-020-00313-x
Ziegler M et al. "Age-related NAD+ decline." PMC (NCBI), PMC7442590, 2020. PMC: PMC7442590
Yusri K et al. "The role of NAD+ metabolism and its modulation of mitochondria in aging and disease." npj Metabolic Health and Disease, vol. 3, article 26, 2025. DOI: 10.1038/s44324-025-00067-0
Berdyshev A et al. "Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells." Biomolecules, vol. 14, no. 12, 2024, p. 1556. DOI: 10.3390/biom14121556
Fang EF et al. "Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease." npj Aging, vol. 11, article 20, 2025. DOI: 10.1038/s41514-025-00291-4
Orr ME et al. "A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment." PMC (NCBI), PMC10828186, 2024. PMC: PMC10828186
de Mello Gindri I et al. "Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review." American Journal of Physiology – Endocrinology and Metabolism, vol. 326, no. 4, 2024, pp. E417–E427. DOI: 10.1152/ajpendo.00242.2023

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.